CIBC Increases WELL Health Technologies (TSE:WELL) Price Target to C$5.25

WELL Health Technologies (TSE:WELL) had its target price increased by CIBC from C$5.00 to C$5.25 in a report published on Friday morning,BayStreet.CA reports.

Separately, Ventum Financial lowered their price objective on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a research report on Tuesday, October 29th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, WELL Health Technologies has a consensus rating of “Moderate Buy” and an average target price of C$7.00.

WELL Health Technologies Trading Up 8.3 %

Shares of WELL stock traded up C$0.41 during mid-day trading on Friday, reaching C$5.34. 4,124,867 shares of the stock traded hands, compared to its average volume of 820,503. WELL Health Technologies has a 1-year low of C$3.41 and a 1-year high of C$5.38. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. The company has a market cap of C$1.33 billion, a price-to-earnings ratio of 9.37, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. The stock’s fifty day simple moving average is C$4.45 and its two-hundred day simple moving average is C$4.33.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.